0000897069-24-001399.txt : 20240617 0000897069-24-001399.hdr.sgml : 20240617 20240617151544 ACCESSION NUMBER: 0000897069-24-001399 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240617 DATE AS OF CHANGE: 20240617 EFFECTIVENESS DATE: 20240617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroEM Therapeutics, Inc. CENTRAL INDEX KEY: 0002026871 ORGANIZATION NAME: IRS NUMBER: 461953474 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-516216 FILM NUMBER: 241047926 BUSINESS ADDRESS: STREET 1: 501 E KENNEDY BOULEVARD STREET 2: SUITE 650 CITY: TAMPA STATE: FL ZIP: 33602 BUSINESS PHONE: 727-252-6120 MAIL ADDRESS: STREET 1: 501 E KENNEDY BOULEVARD STREET 2: SUITE 650 CITY: TAMPA STATE: FL ZIP: 33602 D 1 primary_doc.xml X0708 D LIVE 0002026871 NeuroEM Therapeutics, Inc. 501 E KENNEDY BOULEVARD SUITE 650 TAMPA FL FLORIDA 33602 727-252-6120 DELAWARE None None Corporation true Chuck Papageorgiou 501 E Kennedy Boulevard Suite 650 Tampa FL FLORIDA 33602 Executive Officer Director Chief Executive Officer Jonathan Gordon 501 E Kennedy Boulevard Suite 650 Tampa FL FLORIDA 33602 Director Mitch Larimore 501 E Kennedy Boulevard Suite 650 Tampa FL FLORIDA 33602 Director Other Health Care Decline to Disclose 06b false 2024-05-31 false true true true false 0 500000 360000 140000 false 12 0 0 0 false NeuroEM Therapeutics, Inc. /s/ Chuck Papageorgiou Chuck Papageorgiou Chief Executive Officer 2024-06-17